OpenScience.ink

2 weeks ago • The patient

Patients’ positive treatment experiences with Orforglipron compared to oral Semaglutide in type 2 diabetesQualitative Exit Interviews to Characterize the Positive Treatment Experiences of Patients in the Phase III Trial of Orforglipron Versus Oral Semaglutide for the Treatment of Type 2 Diabetes.

🎖️ Top 10% JournalArticle

2 weeks ago • Nature medicine

Digital-first delivery of GLP-1 hormone therapy in women outside clinical settingsReal-world, digital-first delivery of GLP-1 receptor agonist therapy in women.

Article

2 weeks ago • Nutrients

Fructooligosaccharide intake is linked to better insulin resistance, lower levels of Romboutsia ilealis bacteria, and changes in GLP-1 hormone in obese mice on a high-fat dietDietary Fructooligosaccharide Is Associated with Improved Insulin Resistance, Reduced Romboutsia ilealis Abundance, and Modulation of GLP-1 Production in High-Fat Diet-Induced Obese Mice.

🎖️ Top 10% JournalArticle

2 weeks ago • Molecules (Basel, Switzerland)

How Food Processing and Digestion Influence Natural GLP-1 Hormone Release from Gut CellsFrom Food Structure to L-Cell Exposure: How Processing and Digestion Shape Endogenous GLP-1 Responses.

📖 Top 20% JournalArticle

2 weeks ago • Journal of clinical medicine

Anti-Obesity Drugs Compared to Weight-Loss Surgery for Becoming Eligible for Heart Transplant in Patients with Heart PumpsAnti-Obesity Medications Versus Metabolic Bariatric Surgery as Pathways to Heart Transplant Eligibility in LVAD-Supported Patients: A Narrative Review.

📖 Top 20% JournalArticle

2 weeks ago • Cells

Changes in the GDF-15/GFRAL System and Sensitive Periods After Weight-Loss Surgery: Body, Gut Bacteria, and Drug PerspectivesGDF-15/GFRAL Axis Dynamics and Vulnerability Windows in Bariatric Surgery: Pathophysiological, Microbiomic, and Pharmacological Perspectives.

🎖️ Top 10% JournalArticle

2 weeks ago • Journal of clinical medicine

How Fat Tissue Problems May Be Linked to Blood Clots in VeinsFrom Adipose Tissue Dysfunction to Venous Thromboembolism.

📖 Top 20% JournalArticle

2 weeks ago • Healthcare (Basel, Switzerland)

Weight, safety, and usage of GLP-1 and combined GIP/GLP-1 treatments in obesity and blood sugar disorders across community pharmaciesReal-World Anthropometric Outcomes, Safety, and Use Patterns of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Obesity and Glucose Metabolism Disorder: A Nationwide Multicentre Community Pharmacy Study.

📖 Top 30% JournalArticle

2 weeks ago • International journal of molecular sciences

How Activating GLP-1, GIP, and Glucagon Receptors May Link Obesity and Brain DegenerationGLP-1, GIP, and Glucagon Receptor Agonism at the Obesity-Neurodegeneration Interface: A Narrative Review.

📖 Top 20% JournalArticle

2 weeks ago • Diabetes

Incretin hormones influence the increase of neutrophils around meal timesAn Incretin-Dependent Modulation of Periprandial Neutrophilia.

🥉 Top 5% JournalArticle

2 weeks ago • Nutrients

GLP-1 Treatments and Muscle Health in Obesity: Body Weight, Muscle Strength, and Muscle Loss OutcomesGLP-1-Based Pharmacotherapies and Skeletal Muscle Health in Obesity: A Narrative Review of Body Composition, Muscle Function, and Sarcopenia-Related Outcomes.

🎖️ Top 10% JournalArticle

2 weeks ago • Nutrients

Tirzepatide for Weight Regain After Weight-Loss Surgery: Focus on Sleeve Gastrectomy, Nutrition Safety, and Medical ConsiderationsTirzepatide for Weight Recurrence After Metabolic and Bariatric Surgery: A Critical Review of Direct and Indirect Evidence with Emphasis on Sleeve Gastrectomy, Nutritional Safety, and Clinical Implications.

🎖️ Top 10% JournalArticle

2 weeks ago • The Libyan journal of medicine

Pharmacy students' knowledge and views on side effects of GLP-1 medicines for treating obesityPharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.

📖 Top 50% JournalArticle

2 weeks ago • Journal of internal medicine

Treating Excessive Eating and Obesity in Prader-Willi SyndromeTreatment of hyperphagia and obesity in Prader-Willi syndrome.

🥉 Top 5% JournalArticle

2 weeks ago • European journal of heart failure

Heart and blood vessel outcomes after aortic valve replacement linked to GLP-1 receptor agonist treatmentGLP-1 receptor agonist treatment and cardiovascular outcomes following aortic valve replacement: a nationwide observational study.

🥇 Top 1% JournalArticle

2 weeks ago • Diabetologia

Differences in Glucagon and GIP Hormone Responses After Pregnancy Diabetes in South Asian and Nordic WomenAltered glucagon and GIP responses in South Asian versus Nordic women after gestational diabetes mellitus.

🥈 Top 2% JournalArticle

2 weeks ago • Acta diabetologica

Use of GLP-1 receptor drugs and risk of kidney damage after contrast scans in adults with type 2 diabetes and chronic kidney diseaseGLP-1 receptor agonist use and contrast-associated acute kidney injury after contrast-enhanced CT and CT angiography in adults with type 2 diabetes and chronic kidney disease: a propensity score-matched cohort study.

Article

2 weeks ago • Journal of the American Heart Association

Glucagon-Like Peptide-1 Drugs and New Heart Problems and Death in People with Serious Mental Illness, Type 2 Diabetes, and ObesityGlucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.

🥉 Top 5% JournalArticle

2 weeks ago • Progress in neuro-psychopharmacology & biological psychiatry

Using glucagon-like peptide-1 receptor activators to reduce brain inflammation and their possible treatment role in schizophreniaModulating neuroinflammation with glucagon-like peptide-1 receptor agonists: a scoping review exploring their therapeutic potential in schizophrenia.

Article

2 weeks ago • Cells

Possible Overlap Between GLP-1 Receptor Signals and Liver Cell Protein TAZ in Metabolic Liver Disease: From Metabolism Balance to Liver ScarringPotential Physiological Convergence Between GLP-1 Receptor Signaling and Hepatocyte TAZ in Metabolic Liver Disease: From Metabolic Homeostasis to Fibrotic Remodeling.

🎖️ Top 10% JournalArticle

2 weeks ago • Nutrients

How Gut-Targeting GLP-1 Drugs, Gut Bacteria, and Nutrition May Influence Long-Term Pain Through the Gut-Brain LinkGLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut-Brain Axis.

🎖️ Top 10% JournalArticle

2 weeks ago • Nature communications

How eating different forms of chickpeas affects small intestine metabolism and gut bacteriaEffect of dietary chickpea structures on the small intestine metabolome and microbiome: a randomised crossover trial.

🥈 Top 2% JournalRandomized Controlled Trial

2 weeks ago • Current opinion in pharmacology

Polycystic Ovary Syndrome: Understanding Causes, Current Treatments, and New TherapiesPolycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approaches.

🎖️ Top 10% JournalArticle

2 weeks ago • Archives of medical science : AMS

GLP-1 receptor drugs and their effects on tendon healing: a review and combined analysisGLP-1 receptor agonists and tendon healing: a systematic review and meta-analysis.

📖 Top 30% JournalArticle

2 weeks ago • European heart journal. Case reports

Heart rhythm problem improving after weight-loss drug semaglutide started in a resistant case of irregular heartbeatCardiometabolic therapy for rhythm control: a case report of refractory atrial fibrillation resolving after initiation of semaglutide for obesity.

Case Reports

2 weeks ago • Frontiers in cardiovascular medicine

GLP-1 Treatments for Obesity-Linked Heart Failure with Preserved Pumping Function: A Review Including Related Heart and Metabolic StudiesGLP-1-Based therapies for obesity-related heart failure with preserved ejection fraction: an umbrella review incorporating broader heart failure and cardiometabolic evidence.

📖 Top 20% JournalSystematic Review

2 weeks ago • Current atherosclerosis reports

GLP-1 Receptor Drugs and Lipoprotein (a): Understanding Their Role and Importance in Heart DiseasesGLP-1 Receptor Agonists and Lipoprotein (a): Insights, Gaps and Clinical Implications in Cardiovascular Diseases.

🎖️ Top 10% JournalArticle

2 weeks ago • Journal of doctoral nursing practice

Use of Tirzepatide and Semaglutide for Prediabetes and Heart-Related Health in Rural Primary CareA Retrospective Chart Review of Tirzepatide and Semaglutide Use in Prediabetes Management and Cardiometabolic Outcomes in a Rural Primary Care Setting.

Article

2 weeks ago • Addictive behaviors

Semaglutide's effects and brain mechanisms in alcohol use disorderExploring semaglutide for alcohol use disorder: A review of clinical efficacy and neurobiological mechanisms.

🎖️ Top 10% JournalArticle

2 weeks ago • Plastic and reconstructive surgery

Effects of GLP-1 Drugs on Recovery After Cosmetic and Body Shaping SurgeryImpact of GLP-1 Agonists on Post-Operative Outcomes in Aesthetic & Body Contouring Surgery: A Systematic Review & Meta-Analysis.

📖 Top 20% JournalArticle

← prevpage 10 of 16next →

Latest GLP-1 Therapies Research Papers